Skip to content
Calculator

Grey-Market Encyclopedia · The 2025 crackdown

The 2025 China crackdown, and what happened to your supplier

Many buyers remember 2025 as the year a Chinese crackdown took their supplier. Here is what governments, courts and the analysts who trace payments actually reported, dated, and what usually happens when a seller goes quiet: to your order, to your money, and to the name on the website.

Last updated October 28, 2026 · Reviewed by Grey Peptides Editorial Board · ✓ Every claim sourced · No products sold, no seller named

📋 Key takeaways

We found no report, from any government, court or major news outlet, of a Chinese crackdown aimed at peptide sellers in 2025. What China did that year was aimed at fentanyl precursors and nitazenes: new controls in June and July, export licences for North America in November, and police cases reported from December.12378

The companies caught up in it were mostly the other way round from the usual story. Analysts who trace crypto payments describe Chinese chemical suppliers known for fentanyl precursors that added peptides to their catalogues, not peptide sellers with drugs on the side.910

Payments to these vendors kept rising through 2025.10 Individual sellers did close: one Shanghai-based former precursor supplier that had moved into peptides shut down in September 2025.9 Others are documented carrying on under a new company name.9520

When a seller you paid in crypto disappears, there is usually no way to get the money back,21 and a new seller claiming to be the old one deserves the checks below, not trust it inherited (our reasoning).


On this page

  1. The short answer
  2. What happened, and when
  3. Why it happened, and what was targeted
  4. What it did to peptide supply
  5. When a seller disappears: your order and your money
  6. How sellers reappear under new names
  7. How to judge a seller that may be a rebrand
  8. "What happened to my supplier?"
  9. Frequently asked questions
  10. Related on Grey Peptides
  11. Sources

The short answer

If your supplier went quiet in 2025, you are not imagining a pattern: that year brought a run of actions against Chinese chemical companies, by both China and the United States, along with changes to how small parcels enter the US. But no source we could find reports a Chinese operation aimed at peptide sellers, and none names peptides as a target. The actions named fentanyl precursors, nitazenes and cutting agents.12347 Some of the companies selling peptides were the same companies selling those chemicals,910 so an action aimed at the chemicals could take a peptide catalogue down with it (our reasoning).

That is close to the common understanding, with three differences. There was no single summer crackdown: the actions were spread from June 2025 to early 2026. The companies were chemical suppliers that added peptides, not peptide shops with drugs on the side. And the peptide trade measured by payments grew through 2025 rather than shrinking.1027

What happened, and when

Every date below is from the source cited beside it. Actions in bold were taken by a government.

DateWhoWhat was reported
May 2, 2025United StatesGoods from China and Hong Kong lost duty-free 'de minimis' treatment for low-value imports; mail shipments became subject to duties collected by the carrier (trade advisory).14 The suspension was later extended to all countries.1
June 19, 2025China (National Narcotics Control Commission)All nitazenes and 12 other new psychoactive substances added to China's list of controlled drugs.2
July 20, 2025ChinaTwo fentanyl precursors, 4-piperidone and 1-boc-4-piperidone, placed under control from this date, announced in June (Reuters).3 By June, China had scheduled all the fentanyl precursors listed by the International Narcotics Control Board, the Congressional Research Service says.1
July 2025US Drug Enforcement AdministrationIts annual threat assessment said some China-based chemical companies "may be reluctant to supply controlled precursors overseas" because of China's scheduling actions (as quoted by the Congressional Research Service).1
Late August 2025Postal services abroadPostal services in a number of countries paused parcels to the US ahead of the end of de minimis for all countries on August 29 (news report).15
September 3, 2025US Department of JusticeA grand jury indictment of three US citizens, 22 Chinese nationals and four Chinese pharmaceutical companies on fentanyl distribution and money-laundering conspiracy charges, over cutting agents sold through companies "purporting to be online pharmacies and legitimate chemical companies" and paid in cryptocurrency.4
September 3, 2025US TreasurySanctions on a China-based chemical company and two individuals for selling nitazenes and cutting agents to US buyers. Treasury noted the company kept operating after an earlier indictment was unsealed in October 2024.5 A blockchain analytics firm later reported that its catalogue also listed peptides.10
September 2025US Food and Drug AdministrationImport Alert 66-80: bulk GLP-1 ingredients (semaglutide, tirzepatide and others) from foreign makers not on FDA's 'Green List' may be detained without examination.1617
September 2025Industry reportA Shanghai-based supplier that analysts had tracked as a large fentanyl-precursor seller, and that had been selling peptides since early 2025, shut down.9
November 1, 2025White HouseA US-China deal under which, the US said, China would "halt the flow of precursors used to make fentanyl into the United States", stop shipments of certain designated chemicals to North America and tightly control others worldwide; the US cut its fentanyl-related tariffs from November 10.6
November 10, 2025China (Ministry of Commerce, Ministry of Public Security and others)Exports of 13 precursor chemicals to the US, Mexico and Canada now need a licence, effective immediately, with a notice warning exporters about high-risk destinations and telling postal, courier and freight companies to watch for them.7
December 2025China (Ministry of Public Security)The ministry said China and the US "have jointly investigated multiple cases" (as quoted by the Congressional Research Service).1 A provincial fentanyl-precursor task force was set up in Hubei under a ministry directive.8
December 10, 2025US federal court (N.D. Indiana)The owner and an employee of a US online seller of peptides, hCG and SARMs pleaded guilty; both were sentenced on July 30, 2026, the owner to five years and ten months.19 A US case, not a Chinese one.
December 2025US Customs and Border ProtectionOfficers in Cincinnati made their first seizure of a 'master carton' (one box of many individually labelled parcels from China, declared as something else), according to a Wall Street Journal report (news report).11 By April 2026 CBP said it had stopped more than 300 such attempts, carrying about 5,000 parcels of unapproved injectables (news report).18
March 2026China (Hubei police)State media reported 22 cases investigated through February, seven arrests, four companies penalised and more than 200 websites shut down; one company sold precursor chemicals and stimulants (AP).8

Two actions outside the US and China belong on the same timeline. Operation SHIELD VI, coordinated by Europol and run in 30 countries from April to November 2025, targeted illicit medicines and doping substances: more than 3,350 people were prosecuted and 66 websites taken down.12 Iceland's customs service reported seizing more than 5,000 vials of peptides from China during the operation, its first peptide seizure.13

Why it happened, and what was targeted

The reason given in every government source is fentanyl. The US imposed fentanyl-related tariffs on Chinese goods from February 2025, citing China's alleged failure to stop precursor suppliers;1 the November deal traded tariff cuts for Chinese controls on precursor chemicals.6 China's own measures name precursors and new psychoactive substances,237 and the Hubei task force's cases concerned precursors, stimulants and companies set up to sell them abroad.8 We found no Chinese or US statement in 2025 that names peptides as a target.

Peptides enter the story through the companies, not the policy. Two blockchain analytics firms, which trace payments to wallets they attribute to sellers, reported in 2026 that Chinese chemical manufacturers known for fentanyl precursors had moved into peptides. One counted more than 150 Chinese chemical manufacturers accepting cryptocurrency, about three in four of them listing both precursors and peptides, and called that a lower bound, because some had stopped listing precursors openly and quoted them only in private messages.10 The other found suppliers it had tracked for precursors selling weight-loss and cosmetic peptides from early 2025, and described the move as a way to earn revenue away from the threat of drug enforcement.9 A Wall Street Journal report in October 2026 put the overlap at at least 50 of about 200 former precursor sellers that one firm tracked (news report).11

So the usual telling has the direction reversed. These were not peptide shops caught selling drugs on the side; the documented cases are chemical companies with a precursor trade that added peptides, several of them as enforcement on precursors tightened.910 An action aimed at a company's precursor business could still end its peptide sales too, if the company closed, lost its website or stopped shipping to the US (our reasoning; no source reports a peptide catalogue closed for that reason alone).

What it did to peptide supply

Volume did not fall. One analytics firm measured payments to Chinese vendors listing both precursors and peptides at 28.2 million US dollars in 2023, 33.8 million in 2024 and 37.3 million in 2025, a high, which it noted came despite US enforcement and Chinese crackdowns.10 The other measured payments to peptide vendors growing for six straight quarters to 32 million dollars in the first quarter of 2026.9 US customs figures cited by the New York Times showed imports of hormone and peptide compounds from China roughly doubling, to 328 million dollars in the first three quarters of 2025 (news report; the category also covers lawful compounding supply).27

Some sellers went dark. The one closure we found documented with a date is the Shanghai-based former precursor supplier that shut in September 2025.9 The other firm notes that not all of the vendors it identified are still active, without saying how many closed or when.10 Neither attributes a closure to a specific government action.

Delays came mostly from parcel rules. The end of de minimis for Chinese goods in May 2025, and for everyone in August, changed how every small parcel from China was declared and charged, and postal services in several countries briefly stopped accepting US-bound parcels in late August (trade advisory and news report).1415 We found no report measuring the effect on peptide orders. From December 2025, CBP's master-carton seizures stopped peptide parcels directly.1118

Prices. We found no reliable report of grey-market peptide prices rising or falling because of the 2025 actions (our search, October 28, 2026). Figures on forums and seller sites are not sources this site uses.

When a seller disappears: your order and your money

A seller that stops answering may have closed, been shut down, lost its payment channels, had stock seized, or simply taken the money (our reasoning; the sources above document examples of the first three). For the buyer the result is the same, and it depends mainly on how the order was paid.

  • Paid in cryptocurrency. The Federal Trade Commission says crypto payments "typically are not reversible" and do not come with the legal protections of cards.21 A transfer to a seller that has disappeared is, in practice, gone (our reasoning).
  • Paid by credit card. The Fair Credit Billing Act lets a card holder dispute a charge for goods not delivered as agreed, in writing to the card issuer within 60 days after the first bill showing it was sent.22 Few grey-market sellers take cards, which is part of why the crypto case is the usual one (see financial risks).
  • Parcel already shipped. A parcel may still arrive, or it may be stopped at the border. FDA can refuse an unapproved drug and, as of March 2026, can destroy a refused drug worth $2,500 or less without offering to send it back; it says it generally does not pursue its costs from individual consumers.28 Nobody refunds the price paid to the seller.
  • Store credit, points or a 'wallet' balance with the seller. These live on the seller's own system and disappear with it (our reasoning).

Two things are worth doing anyway. Losses to online sellers can be reported to the FBI's Internet Crime Complaint Center, which counts non-delivery as a fraud category;26 a report does not bring money back, but it is how such cases are counted. And be wary of anyone who contacts you offering to recover the money: the FTC warns that refund and recovery offers are a common follow-on scam, that a legitimate helper will not charge upfront, and that none can guarantee your money back.24

How sellers reappear under new names

A seller that disappears is not always gone. The documented ways back, with their sources:

  • A new company name. One analytics firm describes a Chinese supplier of drug precursors that set up "a corporate alter-ego", a second company, which now sells weight-loss and cosmetic peptides.9
  • The same company, a different product line. Another supplier kept its name and the same phone number it had used for precursor sales, and appeared on forums offering peptides.9 Some vendors removed precursors from their public listings while still quoting them privately.10
  • Carrying on after enforcement. The Treasury says the company it sanctioned in September 2025 kept selling after its October 2024 indictment.5 A US case from 2015 shows the same pattern at home: after search warrants were executed at two peptide companies in 2012, their owner ran the business from his home and sold through a different website, until he pleaded guilty.20

New names and new websites are cheap to make, while a buyer's trust is built on an old name (our reasoning). That is why a seller that reappears often leans on its history: "we used to be X", the same chat handle, the same packaging. None of those can be checked by a buyer, and each can be copied by someone with no link to the old seller (our reasoning).

How to judge a seller that may be a rebrand

This is not a guide to buying, and none of these checks makes an unapproved product safe or legal (see physical risks and legal risks). They are ways to test a claim of continuity, and they apply to any seller claiming to be the successor of one you knew.

  • Domain age. ICANN's free lookup tool shows public registration data for a domain, including the date it was registered.25 A site claiming years of history on a domain registered weeks ago is telling you something (our reasoning). An old domain proves only that someone has held it, not who.
  • Testing history. A new name starts with no test record of its own. A certificate carried over from the old seller is a claim about someone else's batch; only a test of the product you received, by a laboratory you chose, tells you about it (our reasoning). Our guide to checking a seller's claims and published test results explain what a certificate can and cannot show.
  • Payment methods. A switch to crypto-only, or to a payment app in a private individual's name, removes the dispute rights described above.2122 The FTC's general advice is to search a seller's name with words like "review", "complaint" or "scam" before paying.23
  • Offers that are too good. The FTC warns that steeply discounted name-brand goods "might be fakes".23 Large launch discounts, prepaid bulk deals and 'loyalty' offers to old customers ask for money before any track record exists (our reasoning).
  • Old community handles. A familiar username on a new site proves only that someone controls, or copied, that name. Accounts are sold, lost and imitated, and an exit scam can follow the same pattern as a real return (our reasoning). Research on online drug markets found that of 21 major dark-web markets that closed from September 2019, ten closures were exit scams.29

"What happened to my supplier?"

People search for one seller's name with that question after a site goes offline, emails bounce or a chat goes silent. We do not answer it for any named seller, because this site names none. But the answer usually falls into one of a few cases, and the evidence for each is public in a different place (our reasoning, drawing on the cases above):

  1. It was charged, sanctioned or shut by a government. Look for a press release from the US Department of Justice, the Treasury or FDA, or a report of a Chinese police case. These name their targets, often by company name rather than website brand.45819
  2. It closed or changed course on its own. Some suppliers closed without any announced action against them.9 Others moved away from a product line, or from US customers, as controls changed.110
  3. Its parcels or payments stopped. Seizures, new import rules and payment restrictions can end a seller's US business without ending the seller (our reasoning from the timeline above).11141618
  4. It took the money. An exit scam looks exactly like a closure from the outside.29
  5. It came back under another name. See the checks above before trusting the claim.

If you are trying to tell which happened, an official record is the only kind of answer that can be checked. Rumour in a chat is not one, and neither is a new site saying it is the old one (our reasoning).


Frequently asked questions

Was there a Chinese crackdown on peptide sellers in 2025?

Not one we could find reported. China's 2025 measures targeted fentanyl precursors and nitazenes: controls in June and July, export licences for the US, Mexico and Canada in November, and police cases from December. None named peptides. Some companies hit by those measures also sold peptides.237810

Why did so many peptide suppliers disappear in 2025?

Sources document several causes: precursor suppliers that also sold peptides came under pressure from China and the US, at least one closed in September 2025, and US parcel and import rules changed in May, August and September. Payments to these vendors still rose over the year.19101416

Can I get my money back if my supplier vanished?

If you paid in cryptocurrency, usually not: the FTC says crypto payments typically are not reversible. A credit card charge for goods not delivered can be disputed with the issuer within 60 days of the bill.2122

Is the new site claiming to be my old supplier the same seller?

You cannot tell from its word. One documented supplier created a second company to sell peptides; anyone can copy a name or a handle. Check the domain's registration date and the payment terms, and treat its testing history as starting from zero.925

Someone offered to recover my lost money. Is that real?

Treat it as a likely scam. The FTC says legitimate helpers do not charge upfront fees and cannot guarantee you will get your money back.24


Grey market hub Buyer's guide: start here Physical risks Financial risks Legal risks How buyers find sellers, and the scams Contamination and skin reactions US warehouses and domestic stock What 'research use only' means Chinese peptides explained Peptide raves and group buys Peptides on Amazon, Temu and TikTok Shop How to evaluate a peptide vendor Purity is not safety Grey-market glossary

Sources

Government releases and court records are linked; analytics-firm reports and news articles that name companies are cited without a link, because this site names and links no seller (Standing rule 3 (c)). News is labelled as news. All read October 28, 2026. Not legal advice.

  1. Congressional Research Service. China Primer: Illicit Fentanyl and China's Role (In Focus IF10890), updated October 7, 2026. Read October 28, 2026. Source
  2. Xinhua. China places all nitazenes, 12 other NPS under narcotic control. China Daily Hong Kong, June 19, 2025 (updated June 20, 2025). News report of the National Narcotics Control Commission's announcement; read October 28, 2026. Source
  3. Reuters. China moves on fentanyl crackdown as tensions with US over tariffs persist. June 26, 2025, as republished by The Express Tribune. News report; read October 28, 2026. Source
  4. U.S. Department of Justice, Office of Public Affairs. Grand jury indicts three U.S. citizens, 22 Chinese nationals and four Chinese pharmaceutical companies. Press release 25-904, September 3, 2025 (Standing rule 3 (g): linked, recipients not named). Read October 28, 2026. Source
  5. U.S. Department of the Treasury. Treasury sanctions China-based chemical company to combat synthetic opioid trafficking. Press release, September 3, 2025 (Standing rule 3 (g)). Read October 28, 2026. Source
  6. The White House. Fact Sheet: President Donald J. Trump strikes deal on economic and trade relations with China. November 1, 2025, as archived by The American Presidency Project (UC Santa Barbara). Read October 28, 2026. Source
  7. China Daily. Control of precursor chemical exports tightened. November 12, 2025: the Ministry of Commerce, Ministry of Public Security, Ministry of Emergency Management, General Administration of Customs and National Medical Products Administration on licences for 13 precursors to the US, Mexico and Canada, and the National Narcotics Control Commission's notice to exporters. News report; read October 28, 2026. Source
  8. Associated Press. Hubei province arrests 7, shuts websites in fentanyl crackdown. Macau Daily Times, March 20, 2026, reporting Hubei Daily and Xinhua. News report; read October 28, 2026. Source
  9. Chainalysis Team. The $100 Million Crypto 'Looksmaxxing' Boom: How Chinese Cartel Suppliers Pivoted to the Gray-Market Peptide Ecosystem. Chainalysis blog, June 4, 2026 (modified June 5, 2026). Industry report; read October 28, 2026. Cited without a link: the report names sellers.
  10. TRM Labs. Americans are buying peptides from the same Chinese chemical vendors selling fentanyl precursors; sales up 32% since 2023. TRM Labs blog, October 6, 2026. Industry report; read October 28, 2026. Cited without a link: the report names sellers.
  11. Jung M. Chinese firms that once supplied fentanyl precursors now eye illicit peptide market. The Herald Business (Seoul), October 11, 2026, reporting a Wall Street Journal article of that week. News report; read October 28, 2026. Cited without a link: the article names sellers.
  12. Europol and OLAF, as reported by eucrim. Successful crackdown on pharmaceutical crime (Operation SHIELD VI), eucrim issue 1/2026, March 25, 2026, on the announcement of February 25, 2026. Read October 28, 2026. Source
  13. Iceland Revenue and Customs (Skatturinn). Large quantity of illegal peptides seized in international operation. News release, March 2, 2026. Read October 28, 2026. Source
  14. C.H. Robinson. De minimis ends May 2 for imports from China and Hong Kong origin. Client advisory, April 29, 2025. Trade advisory; read October 28, 2026. Source
  15. Postal services across globe pause US deliveries as tariff shift sows confusion. Insurance Journal, August 22, 2025 (Bloomberg). News report; read October 28, 2026. Source
  16. Anderson K. FDA cracks down on GLP-1 imports. Pharmaceutical Online, September 11, 2025 (Import Alert 66-80 and the Green List). News report; read October 28, 2026. Source
  17. U.S. Food and Drug Administration. Import Alert 66-80: Detention without physical examination of glucagon-like peptide-1 (GLP-1) receptor agonist bulk drug substances. Current revision published October 9, 2026; read October 28, 2026. Source
  18. WHIO Staff. 5K shipments of unapproved weight loss injectable seized in Ohio. WHIO TV 7, April 1, 2026, reporting US Customs and Border Protection in Cincinnati. News report; read October 28, 2026. Source
  19. U.S. Attorney's Office, Northern District of Indiana. Case page for a prosecution of a US online seller of peptides, hCG and SARMs: guilty pleas December 10, 2025; sentencing July 30, 2026 (Standing rule 3 (g): linked, defendants and business not named). Read October 28, 2026. Source
  20. U.S. Attorney's Office, District of Maryland. Owner of bodybuilding drug companies admits selling misbranded drugs. Press release, November 2, 2015 (Standing rule 3 (g)). Read October 28, 2026. Source
  21. Federal Trade Commission. What To Know About Cryptocurrency and Scams. Consumer advice, last modified February 10, 2025; read October 28, 2026. Source
  22. Federal Trade Commission. Using Credit Cards and Disputing Charges (the Fair Credit Billing Act). Consumer advice, last modified April 2, 2024; read October 28, 2026. Source
  23. Federal Trade Commission. Shopping online? Know your retailer and your rights. Consumer blog, June 30, 2021; read October 28, 2026. Source
  24. Federal Trade Commission. Refund and Recovery Scams. Consumer advice, December 14, 2023, last modified August 13, 2026; read October 28, 2026. Source
  25. Alvarez E. Domain registration data advanced lookup functionality now available. ICANN blog, August 2, 2021 (the ICANN Lookup tool, built on RDAP). Read October 28, 2026. Source
  26. Federal Bureau of Investigation, Internet Crime Complaint Center. 2025 Internet Crime Report: Non-Payment/Non-Delivery. Read October 28, 2026. Source
  27. Sun J, Henry J, Agosta H. 'Chinese Peptides' Are the Tech World's Latest Biohacking Fad. The New York Times, January 3, 2026, republished by GV Wire, January 7, 2026; US customs figures as the article gives them. News report; read October 28, 2026. Source
  28. U.S. Food and Drug Administration. Administrative Destruction Authority (Import Basics). Content current as of March 16, 2026; read October 28, 2026. Source
  29. Wang Y, Arief B, Hernandez-Castro J. Dark Ending: What Happens when a Dark Web Market Closes down. Proceedings of the 9th International Conference on Information Systems Security and Privacy (ICISSP 2023), pp. 106-117. Read October 28, 2026. Source

This page describes how the grey market works; it is not legal or medical advice, and it is not a guide to buying. Grey Peptides sells nothing, links to no seller and rates none. If you have taken a product and feel unwell, contact a clinician or Poison Help (1-800-222-1222 in the US).